Analysts have suggested that approval in CSU alone could make the drug a blockbuster, with sales of more than $1 billion a year, and Novartis is running phase 3 trials for chronic inducible urticaria (CINDU) and multiple sclerosis (MS), and phase 2 studies in hidradenitis suppurativa (HS) and food allergy indications
All medications are sourced from licensed 503A compounding pharmacies and are HSA/FSA eligible, making precision weight loss therapy accessible to all 50 states without insurance
References 1.	Zhang Y, Sun B, Feng D, et al
Tirzepatide may also cause additional stomach issues such as constipation, belching, indigestion, and fatigue, and there is a possible risk of low blood sugar, especially when combined with other diabetes medications
Volatile substances Insecticides, even some drugs, provide a better and easier solution to remove from the body
If you are using Wegovy and have questions, talk with your doctor or pharmacist